Skip to main content

Terapie locoregionali e chirurgia oncologica

  • Chapter
Book cover Nuove tecnologie chirurgiche in oncologia

Riassunto

La storia naturale delle neoplasie solide inizia da una malattia confinata in una specifica area anatomica. Nelle neoplasie localizzate, la chirurgia rappresenta il fondamento terapeutico. La radioterapia può svolgere un ruolo curativo in situazioni specifiche, ma in generale, insieme alla chemioterapia, rimane un trattamento adiuvante.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 54.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Bibliografia

  1. Ensminger WD (2001) Intraarterial therapy. In: Perry CM (ed) The chemotherapy source book, 3rd edn. Lippincott Williams & Wilkins, Philadelphia, pp 163–174

    Google Scholar 

  2. Rossi CR, Foletto M, Pilati P et al (2002) Isolated limb perfusion in locally advanced cutaneous melanoma. Semin Oncol 29:400–409

    Article  PubMed  Google Scholar 

  3. Markman M (1998) Intraperitoneal therapy in ovarian cancer. Semin Oncol 25:356–360

    PubMed  CAS  Google Scholar 

  4. Alexander HR, Kemeny NE, Lawrence TS (2005) Metastatic cancer to the liver. In: De Vita VT, Hellmann S, Rosenberg SA (eds) Cancer principles & practice of oncology, 7th edn. Lippincott Williams & Wilkins, Philadelphia, pp 2352–2367

    Google Scholar 

  5. Lise M, Pilati P, Da Pian P et al (2003) Treatment options for liver metastases from colorectal cancer. J Exp Clin Cancer Res 22:149–156

    PubMed  CAS  Google Scholar 

  6. Kemeny N (2007) Presurgical chemotherapy in patients being considered for liver resection. Oncologist 12:825–839

    Article  PubMed  CAS  Google Scholar 

  7. Vadeyar HJ (2007) Current therapeutic options for colorectal liver metastases. Indian J Gastroenterol 26:26–29

    PubMed  CAS  Google Scholar 

  8. Rossi CR, Foletto M, Pilati P et al (2002) Isolated limb perfusion in locally advanced cutaneous melanoma. Semin Oncol 29:400–409

    Article  PubMed  Google Scholar 

  9. Rossi CR, Foletto M, Mocellin S (2004) Hyperthermic isolated limb perfusion with low—dose tumor necrosis factor-alpha and melphalan for bulky in-transit melanoma metastases. Ann Surg Oncol 11:173–177

    Article  PubMed  Google Scholar 

  10. Di Filippo F, Rossi CR, Santinami M et al (2006) Hyperthermic isolation limb perfusion with TNFalpha in the treatment of in-transit melanoma metastasis. In Vivo 20:739–742

    PubMed  Google Scholar 

  11. Hayes AJ, Neuhaus SJ, Clark MA, Thomas JM (2007) Isolated limb perfusion with melphalan and tumor necrosis factor alpha for advanced melanoma and soft-tissue sarcoma. Ann Surg Oncol 14:230–238

    Article  PubMed  Google Scholar 

  12. Eggermont AM, Schraffordt Koops H, Klausner JM et al (1996) Isolated limb perfusion with tumor necrosis factor and melphalan for limb salvage in 186 patients with locally advanced soft tissue extremity sarcomas. The cumulative multicenter European experience. Ann Surg 224:756–764

    Article  PubMed  CAS  Google Scholar 

  13. Noorda EM, Vrouenraets BC, Nieweg OE et al (2003) Isolated limb perfusion with tumor necrosis factor-alpha and melphalan for patients with unresectable soft tissue sarcoma of the extremities. Cancer 98:1483–1490

    Article  PubMed  CAS  Google Scholar 

  14. Gutman M, Inbar M, Lev-Shlush D et al (1997) High dose tumor necrosis factor-alpha and melphalan administered via isolated limb perfusion for advanced limb soft tissue sarcoma results in a >90% response rate and limb preservation. Cancer 79:1129–1137

    Article  PubMed  CAS  Google Scholar 

  15. Cherix S, Speiser M, Matter M et al (2008) Isolated limb perfusion with tumor necrosis factor and melphalan for non-resectable soft tissue sarcomas: long-term results on efficacy and limb salvage in a selected group of patients. J Surg Oncol 98:148–155

    Article  PubMed  Google Scholar 

  16. Hess LM, Benham-Hutchins M, Herzog TJ et al (2007) A meta-analysis of the efficacy of intraperitoneal cisplatin for the front-line treatment of ovarian cancer. Int J Gynecol Cancer 17:561–570

    Article  PubMed  CAS  Google Scholar 

  17. Noma J, Yoshida N (2008) Intraperitoneal chemotherapy for ovarian cancer. Gan To Kagaku Ryoho 35:885–890

    PubMed  Google Scholar 

  18. Xu DZ, Zhan YQ, Sun XW et al (2004) Meta-analysis of intraperitoneal chemotherapy for gastric cancer. World J Gastroenterol 10):2727–2730

    PubMed  Google Scholar 

  19. Moran B, Baratti D, Yan TD et al (2008) Consensus statement on the loco-regional treatment of appendiceal mucinous neoplasms with peritoneal dissemination (pseudomyxoma peritonei). J Surg Oncol 98:277–282

    Article  PubMed  Google Scholar 

  20. Deraco M, Bartlett D, Kusamura S, Baratti D (2008) Consensus statement on peritoneal mesothelioma. J Surg Oncol 98:268–272

    Article  PubMed  Google Scholar 

  21. Esquivel J, Elias D, Baratti D et al (2008) Consensus statement on the loco regional treatment of colorectal cancer with peritoneal dissemination. J Surg Oncol 98:263–267

    Article  PubMed  Google Scholar 

  22. Helm CW, Bristow RE, Kusamura S et al (2008) Hyperthermic intraperitoneal chemotherapy with and without cytoreductive surgery for epithelial ovarian cancer. J Surg Oncol 98:283–290

    Article  PubMed  CAS  Google Scholar 

  23. Bozzetti F, Yu W, Baratti D et al (2008) Locoregional treatment of peritoneal carcinomatosis from gastric cancer. J Surg Oncol 98:273–276

    Article  PubMed  CAS  Google Scholar 

  24. Mir LM, Orlowski S (1999) Mechanisms of electrochemotherapy. Adv Drug Del Rev 35:107–118

    Article  CAS  Google Scholar 

  25. Marty M, Sersa G, Garbay JR et al (2006) Electrochemotherapy—An easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: results of ESOPE study. EJC[Suppl] 4:3–13

    CAS  Google Scholar 

  26. Campana LG, Mocellin S, Basso M et al (2009) Bleomycin-based electrochemotherapy: clinical outcome from a single institution’s experience with 52 patients. Ann Surg Oncol 16:191–199

    Article  PubMed  Google Scholar 

  27. Goldberg SN, Grassi CJ, Cardella JF et al (2005) Image-guided tumor ablation: standardization of terminology and reporting criteria. Radiology 235:728–739

    Article  PubMed  Google Scholar 

  28. Bruix J, Sherman M (2005) Management of hepatocellular carcinoma. Hepatology 42:1208–1236

    Article  PubMed  Google Scholar 

  29. Brunello F, Veltri A, Carucci P et al (2008) Radiofrequency ablation versus ethanol injection for early hepatocellular carcinoma: a randomized controlled trial. Scand J Gastroenterol 43:727–735

    Article  PubMed  Google Scholar 

  30. Veltri A, Moretto P, Doriguzzi A et al (2006) Radiofrequency thermal ablation (RFA) after transarterial chemoembolization (TACE) as a combined therapy for unresectable non-early hepatocellular carcinoma (HCC). Eur Radiol 16:661–669

    Article  PubMed  Google Scholar 

  31. Veltri A, Sacchetto P, Tosetti I et al (2008) Radiofrequency ablation of colorectal liver metastases: small size favorably predicts technique effectiveness and survival. Cardiovasc Intervent Radiol 31:948–956

    Article  PubMed  Google Scholar 

  32. Lencioni R, Crocetti L, Cioni R et al (2008) Response to radiofrequency ablation of pulmonary tumors: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study). Lancet Oncol 9:621–628

    Article  PubMed  Google Scholar 

  33. Veltri A, Garetto I, Pagano E et al (2009) Percutaneous RF thermal ablation of renal tumors: is US guidance really less favorable than other imaging guidance techniques? Cardiovasc Intervent Radiol 32:76–85

    Article  PubMed  Google Scholar 

  34. Veltri A, Calvo A, Tosetti I et al (2006) Experiences in US-guided percutaneous radiofrequency ablation of 44 renal tumors in 31 patients: analysis of predictors for complications and technical success. Cardiovasc Intervent Radiol 29:811–818

    Article  PubMed  Google Scholar 

  35. Goetz MP, Callstrom MR, Charboneau JW et al (2004) Percutaneous image-guided radiofrequency ablation of painful metastases involving bone: a multicenter study. J Clin Oncol 22:300–306

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer-Verlag Italia

About this chapter

Cite this chapter

Rossi, C.R., Comandone, A., Veltri, A. (2011). Terapie locoregionali e chirurgia oncologica. In: Nuove tecnologie chirurgiche in oncologia. Springer, Milano. https://doi.org/10.1007/978-88-470-2385-7_11

Download citation

  • DOI: https://doi.org/10.1007/978-88-470-2385-7_11

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-2384-0

  • Online ISBN: 978-88-470-2385-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics